TheraRadar

Pharma Intelligence, Simplified

Landscape → Urology

Overactive Bladder

182 clinical trials

42 active
/
182 total (since 2015)
6
Phase 1 Active
38 total
16
Phase 2 Active
57 total
9
Phase 3 Active
44 total
16
Phase 4 Active
61 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Levee Medical, Inc. 2 0 0
Cook MyoSite 1 1 1
TBF Genie Tissulaire 1 1 0
Eli Lilly 1 0 0
Trigone Pharma Ltd. 1 0 0
Sarfez Pharmaceuticals, Inc. 1 0 0
Bayer 0 6 0
Urovant Sciences GmbH 0 5 0
Taiho Pharmaceutical Co., Ltd. 0 4 0
GTx 0 2 2
Jeil Pharmaceutical Co., Ltd. 0 4 0
AbbVie 0 3 0
Velicept Therapeutics, Inc. 0 3 0
NCT06873581 RECRUITING
Pivotal Study of Voro Urologic Scaffold
Levee Medical, Inc. n=266
NCT07202884 RECRUITING
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Eli Lilly and Company n=1,000
NCT07429734 NOT YET RECRUITING
Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in Women
Mansoura University n=60
NCT03952299 RECRUITING
Oxybutynin for Post-surgical Bladder Pain and Urgency
University of California, Davis n=100
NCT05878951 RECRUITING
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Northwestern University n=80
NCT06551246 RECRUITING
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
University of Aarhus n=236
NCT06678984 NOT YET RECRUITING
Treated Umbilical Vein Allograft (UVT) Versus Autologous Fascial Pubovaginal Sling in the Treatment of Female Stress Urinary Incontinence
TBF Genie Tissulaire n=96
NCT03104517 ACTIVE NOT RECRUITING
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
Cook MyoSite n=96
NCT06969729 RECRUITING
Evaluation of Clinical Efficacy and Safety of Aortal Stent-Graft Created Using 3D Printing Technology
Samodzielny Publiczny Szpital Kliniczny nr 2 PUM n=100
NCT07366762 COMPLETED
Comparison Between Two Techniques in Treatment of Female Stress Urinary Incontinence
Kafrelsheikh University n=40
NCT04171531 COMPLETED
Sling vs Botox for Mixed Incontinence
NICHD Pelvic Floor Disorders Network n=150
NCT05702827 COMPLETED
Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery
TriHealth Inc. n=148
NCT04641975 TERMINATED
A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)
Astellas Pharma Global Development, Inc. n=26
NCT03149809 COMPLETED
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
VA Office of Research and Development n=77
NCT05390970 COMPLETED
Platelet-Rich Plasma for Stress Urinary Incontinence
Annah J. Vollstedt n=50
NCT03997318 WITHDRAWN
Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)
Cook MyoSite
NCT04103450 COMPLETED
Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia
Urovant Sciences GmbH n=276
NCT03902080 COMPLETED
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
Urovant Sciences GmbH n=1,105
NCT05282069 COMPLETED
A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder
Dong-A ST Co., Ltd. n=607
NCT05493735 COMPLETED
Lidocaine for Pessary Check Pain Reduction
University of South Florida n=66
NCT04084340 COMPLETED
tDCS and Female Urinary Incontinence
Universidade Federal do Piauí n=60
NCT04048356 COMPLETED
Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures
University of New Mexico n=137
NCT03295487 COMPLETED
ToT and Estrogen in Postmenopausal Females
Kasr El Aini Hospital n=210
NCT02660359 TERMINATED
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2
Ipsen n=258
NCT02660138 TERMINATED
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1
Ipsen n=227
NCT04412876 WITHDRAWN
Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study
Far Eastern Memorial Hospital
NCT04026880 WITHDRAWN
Testosterone Effects on Pelvic Floor Muscles
Brigham and Women's Hospital
NCT02352103 COMPLETED
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
Henry Ford Health System n=120
NCT04917315 COMPLETED
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder
Jeil Pharmaceutical Co., Ltd. n=210
NCT03524339 COMPLETED
Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery
University Hospitals Cleveland Medical Center n=132
NCT03583372 COMPLETED
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).
Urovant Sciences GmbH n=506
NCT03492281 COMPLETED
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)
Urovant Sciences GmbH n=1,530
NCT04571346 COMPLETED
Female Sling Procedure
Ain Shams University n=100
NCT02529865 COMPLETED
Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence
Nagoya University n=45
NCT03532789 COMPLETED
Herbal Patch for Overactive Bladder
En Chu Kong Hospital n=66
NCT02614482 COMPLETED
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.
Stéphane Bolduc n=26
NCT03575702 COMPLETED
Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.
R-Pharm n=300
NCT03438422 COMPLETED
Effect of Pollen Extract on Urinary Incontinence
Dr. Santiago Palacios n=160
NCT03463863 COMPLETED
Midurethral Sling With Autologus Rectus Sheath
sarah mohamed hassan n=70
NCT02805452 TERMINATED
Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer
Center Eugene Marquis n=4
NCT03296748 COMPLETED
Correction of Asymptomatic 2nd Degree Cystocele in Patient With Stress Incontinence
Kasr El Aini Hospital n=123
NCT02334878 COMPLETED
Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence
Ain Shams Maternity Hospital n=50
NCT03059134 COMPLETED
Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
Buddhist Tzu Chi General Hospital n=168
NCT02485067 COMPLETED
Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
SK Chemicals Co., Ltd. n=384

Data: ClinicalTrials.gov